pyridostigmine bromide has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferlin, EL; Harthmann, AD; Moraes, RS; Souza, WI | 1 |
| Arvat, E; Bertaina, S; Bruno, G; Camanni, F; Ghigo, E; Maccario, M; Martina, V; Tagliabue, M; Zumpano, E | 1 |
1 trial(s) available for pyridostigmine bromide and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of peripheral cholinergic stimulation on autonomic modulation in Type 2 diabetes with autonomic neuropathy: a randomized controlled trial.
Topics: Analysis of Variance; Autonomic Nervous System Diseases; Cholinesterase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Humans; Pyridostigmine Bromide | 2014 |
1 other study(ies) available for pyridostigmine bromide and Diabetic Neuropathies
| Article | Year |
|---|---|
Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Pyridostigmine Bromide; Reference Values | 1997 |